Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Novel Receptor Partners and Function of Receptor Activity-modifying Proteins
Ist Teil von
The Journal of biological chemistry, 2003-01, Vol.278 (5), p.3293-3297
Ort / Verlag
United States: American Society for Biochemistry and Molecular Biology
Erscheinungsjahr
2003
Quelle
MEDLINE
Beschreibungen/Notizen
The receptor activity-modifying proteins (RAMPs) comprise a family of three accessory proteins that heterodimerize with the
calcitonin receptor-like receptor (CL receptor) or with the calcitonin receptor (CTR) to generate different receptor phenotypes.
However, RAMPs are more widely distributed across cell and tissue types than the CTR and CL receptor, suggesting additional
roles for RAMPs in cellular processes. We have investigated the potential for RAMP interaction with a number of Class II G
protein-coupled receptors (GPCRs) in addition to the CL receptor and the CTR. Using immunofluorescence confocal microscopy,
we demonstrate, for the first time, that RAMPs interact with at least four additional receptors, the VPAC1 vasoactive intestinal
polypeptide/pituitary adenylate cyclase-activating peptide receptor with all three RAMPs; the glucagon and PTH1 parathyroid
hormone receptors with RAMP2; and the PTH2 receptor with RAMP3. Unlike the interaction of RAMPs with the CL receptor or the
CTR, VPAC1R-RAMP complexes do not show altered phenotypic behavior compared with the VPAC1R alone, as determined using radioligand
binding in COS-7 cells. However, the VPAC1R-RAMP2 heterodimer displays a significant enhancement of agonist-mediated phosphoinositide
hydrolysis with no change in cAMP stimulation compared with the VPAC1R alone. Our findings identify a new functional consequence
of RAMP-receptor interaction, suggesting that RAMPs play a more general role in modulating cell signaling through other GPCRs
than is currently appreciated.